Colorado’s wild virus year wasn’t — and was — the new normal

Brasil Notícia Notícia

Colorado’s wild virus year wasn’t — and was — the new normal
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 denverpost
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 72%

Some pathogens -- like respiratory syncytial virus, or RSV, and streptococcus bacteria, or strep -- did damage that children's hospitals called 'unprecedented.'

With sniffles as a near-constant companion this fall and winter, and previously obscure viruses becoming household names in Colorado, you’re not alone if you wondered whether this past year was normal.

That doesn’t mean fall and winter weren’t miserable for some, especially after two years with minimal viral spread. A Januaryfound about 38% of people reported someone in their home had been sick from flu, COVID-19 or RSV in the previous month. An average toddler who attends daycare gets 10 to 12 respiratory viruses over the course of the six to eight months when they most commonly spread, but they had far fewer illnesses while people were masking and practicing social distancing earlier in the pandemic, he said.Respiratory syncytial virusin fall 2022. At the peak in November, 295 children and 31 adults were admitted to hospitals with RSV in the Denver area.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

denverpost /  🏆 13. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

FDA approves GSK's RSV vaccine for older adults, world's first shot against virusFDA approves GSK's RSV vaccine for older adults, world's first shot against virusThe FDA's approval is a victory for GSK in a race against Pfizer and Moderna to bring a shot that targets respiratory syncytial virus to the market.
Consulte Mais informação »

First-ever RSV vaccine approved by FDA for adults 60 and overFirst-ever RSV vaccine approved by FDA for adults 60 and overThe Food and Drug Administration (FDA) has approved the first respiratory syncytial virus (RSV) vaccine for use in the U.S., the public health agency announced on Wednesday.
Consulte Mais informação »

US approves 1st vaccine for RSV after decades of attemptsUS approves 1st vaccine for RSV after decades of attemptsAfter decades of failure in the quest for an RSV vaccine, doctors are anxious to finally have something to offer — especially after a virus surge that strained hospitals last fall.
Consulte Mais informação »

FDA Approves First RSV Vaccine for Older AdultsFDA Approves First RSV Vaccine for Older AdultsThis is the first approved RSV vaccine in the United States, and the world’s first vaccine for older adults.
Consulte Mais informação »

FDA approves world's first RSV vaccine for older adultsFDA approves world's first RSV vaccine for older adultsThe U.S. Food and Drug Administration (FDA) on Thursday approved the world's first respiratory syncytial virus (RSV) vaccine for older adults. via JessicaDenver7
Consulte Mais informação »

InnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For DoctorsInnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For DoctorsInnovationRx: The FDA OKs The First RSV Vaccine; Microsoft’s AI Play For Doctors by TheAlexKnapp, katiedjennings
Consulte Mais informação »



Render Time: 2025-02-28 02:09:08